CA2446254A1 - New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits - Google Patents

New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits Download PDF

Info

Publication number
CA2446254A1
CA2446254A1 CA002446254A CA2446254A CA2446254A1 CA 2446254 A1 CA2446254 A1 CA 2446254A1 CA 002446254 A CA002446254 A CA 002446254A CA 2446254 A CA2446254 A CA 2446254A CA 2446254 A1 CA2446254 A1 CA 2446254A1
Authority
CA
Canada
Prior art keywords
minerals
trace
weight
synergetic
elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002446254A
Other languages
French (fr)
Other versions
CA2446254C (en
Inventor
Ravi Shrivastava
M. Hema Belani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0204905A priority Critical patent/FR2838645B1/en
Priority to AU2003254759A priority patent/AU2003254759B2/en
Application filed by Individual filed Critical Individual
Priority to CA2446254A priority patent/CA2446254C/en
Priority to JP2003364492A priority patent/JP2005126379A/en
Publication of CA2446254A1 publication Critical patent/CA2446254A1/en
Application granted granted Critical
Publication of CA2446254C publication Critical patent/CA2446254C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Nearly 40% population of the developed countries in the world have the problem of excess weight. Up till now, no correlation was established between the deficiencies of certain specific vitamins , minerals and trace-elements with the problem of excess weight. None of the weight reduction strategies proposed till today took into consideration the reduced capacity of the cells to eliminate the intracellular lipid deposits which is the real cause of excess weight.
After many years of research, we discovered that a synergetic composition of certain specific vitamins, minerals and trace-elements stimulate the intracellular lipid elimination capacity of cells thereby helping to reduce body weight in a very short period of time without any side-effects and without the rebound effect often observed at the end of the dieting period. The methods of preparation of such solid or liquid compositions for oral or topical application are known.
These synergetic compositions can be used either alone or in association with products commonly used to reduce weight, with specific diets, with apparatuses for physical exercise or muscular electrostimulation which are commonly employed to increase energy loss.

Claims (7)

1. Oral use of a synergetic composition containing at lease two vitamins among vitamin A, vitamin B2, vitamin B9 and vitamin E
along with at least two minerals or trace-elements among magnesium, zinc, copper and selenium to eliminate intracellular lipids and the toxic wastes accumulated in the body.
2. Oral use of a synergetic composition according to the claim 1 to reduce intracellular lipid accumulation for the treatment of excess weight and lipid metabolism related problems.
3. Use of a synergetic composition according to the claims 1 to 2 in association with an another oral composition containing ingredients which stimulate thermogenesis, have a cholagogue or choleretic effect or which are known to reduce body weight for the treatment of obesity.
4. Use of a synergetic composition according to the claims 1 to 2 in combination with a hypocaloric diet, protein rich diet, or a diet stimulating intestinal transit.
5. Use of a synergetic composition according to the claims 1 to 2 in combination with a apparatus for physical exercise or for muscular electrostimulation.
6. A combination of compositions defined in the claims 1 to 5 as a pharmaceutical, cosmetic, dietary, or nutritional product.
7. A combination of compositions as defined in the claims 1 to 5 with a pharmaceutically, nutritionally or cosmetically acceptable excipient.
CA2446254A 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits Expired - Fee Related CA2446254C (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0204905A FR2838645B1 (en) 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS
AU2003254759A AU2003254759B2 (en) 2002-04-19 2003-10-17 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
CA2446254A CA2446254C (en) 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
JP2003364492A JP2005126379A (en) 2002-04-19 2003-10-24 New synergetic composition of vitamins, minerals and trace element for stimulating elimination of intracellular lipid deposit

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0204905A FR2838645B1 (en) 2002-04-19 2002-04-19 NOVEL SYNERGISTIC COMPOSITIONS OF VITAMINS, MINERALS AND TRACE ELEMENTS TO STIMULATE THE ELIMINATION OF INTRACELLULAR LIPIDS
AU2003254759A AU2003254759B2 (en) 2002-04-19 2003-10-17 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
CA2446254A CA2446254C (en) 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
JP2003364492A JP2005126379A (en) 2002-04-19 2003-10-24 New synergetic composition of vitamins, minerals and trace element for stimulating elimination of intracellular lipid deposit

Publications (2)

Publication Number Publication Date
CA2446254A1 true CA2446254A1 (en) 2005-04-22
CA2446254C CA2446254C (en) 2012-01-03

Family

ID=34714413

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2446254A Expired - Fee Related CA2446254C (en) 2002-04-19 2003-10-22 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits

Country Status (4)

Country Link
JP (1) JP2005126379A (en)
AU (1) AU2003254759B2 (en)
CA (1) CA2446254C (en)
FR (1) FR2838645B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598063A1 (en) * 2003-10-22 2005-11-23 Ravi Shrivastava Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids
FR2883472B1 (en) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale USE OF A CHLOROGENIC ACID AS A SLIMMING ACTIVE INGREDIENT
CA2641420C (en) * 2006-02-03 2013-06-25 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
DE112020001186A5 (en) * 2019-03-11 2022-03-17 Gerhard Hermann dietary supplements

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity
JPS5592645A (en) * 1978-12-29 1980-07-14 Yoshiko Saeki Food composition
US5340315A (en) * 1991-06-27 1994-08-23 Abbott Laboratories Method of treating obesity
JPH08259461A (en) * 1995-03-24 1996-10-08 Snow Brand Milk Prod Co Ltd Lipometabolism improver
FR2733418B1 (en) * 1995-04-28 1997-08-01 Ravi Shrivastava NEW COMBINATIONS COMPRISING (-) HYDROXYCITRATE AND INCLUDING IN PARTICULAR NEW THERAPEUTIC ACTIVITIES
FR2747307B1 (en) * 1996-04-11 1998-07-10 Ravi Shrivastava APPLICATION AS MEDICAMENT OF CERAMIDES AND PARTICULARLY PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2747308B1 (en) * 1996-04-11 1998-07-10 Shrivastava Ravi ASSOCIATION OF MARGOUSIER, (-) HYDROXYCITRATE AND CERAMIDES AND COMPOSITIONS CONTAINING THEM
FR2754820B1 (en) * 1996-10-22 1999-10-22 Ravi Shrivastava MAGNESIUM (-) HYDROXYCITRATE, PREPARATION METHOD, APPLICATIONS, AND PARTICULARLY PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2801214B1 (en) * 1999-11-24 2002-09-20 Ravishekhaz Shrivastava USE IN COMBINATION OF NEW SOLID AND NON-SOLID COMPOSITIONS FOR TREATING ABDOMINAL DILATION
JP2004515508A (en) * 2000-12-16 2004-05-27 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング COMPOUND HEALTH PROMOTING COMPOSITION

Also Published As

Publication number Publication date
AU2003254759B2 (en) 2009-09-03
CA2446254C (en) 2012-01-03
FR2838645B1 (en) 2004-05-28
FR2838645A1 (en) 2003-10-24
JP2005126379A (en) 2005-05-19
AU2003254759A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
US6277842B1 (en) Dietary supplemental method for fat and weight reduction
US9387168B2 (en) Chewing gum with tomatidine
Campbell Synergistic use of higher-protein diets or nutritional supplements with resistance training to counter sarcopenia
US20070065456A1 (en) Nutritional supplements
EP3590521B1 (en) Synergistic dietary supplement compositions for enhancing physical performance and energy levels
CA2996725C (en) Compositions comprising an urolithin compound
US20020150649A1 (en) Nutritional supplement for pediatric obesity
AU2010206791B2 (en) A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
CA2446254A1 (en) New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
GB2585619A (en) A supplement
EP1410722A1 (en) Weight loss kit and method for losing weight
EP3320785A1 (en) Composition, containing extracts ofdipsacus asperoides
CN110326776A (en) A kind of integration of drinking and medicinal herbs compound formulation of the raising immunity of suitable spacefarer
WO2017179707A1 (en) Combination for improving frailty
JP2004329047A (en) Dietary supplement
US20190160138A1 (en) Dietary supplement for gluten reaction
US20050266096A1 (en) New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
Pearce Sports supplements: a modern case of caveat emptor
WO2020210540A2 (en) Nutrient compositions and methods for administering a nutrient composition
CN101474299B (en) Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes
CN101474305A (en) Pharmaceutical composition for reducing blood sugar and blood fat
EP1598063A1 (en) Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids
Buy 7 Ways to Keep Muscle As You Age & Reduce Age-related Muscle Loss by Mr Run| 17 Jan 2023| Health & running, Nutrition for runners, Older runners
O'Reilly The Best Types of Supplements for Performance, Weight Loss, and Health Find out which supplements can (actually) help take your performance and health to the next level.
WO2013108263A1 (en) Pharmaceutical formulation to reduce inflammation of bones and joint friction with improved cartilage quality

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20171023